• Nextleaf (OILS) has announced audited financial results for fiscal 2022, which ended September 30, 2022
  • Revenue was $5,351,509, up by 52 per cent YoY
  • The company ended 2022 as a top 5 seller of CBD oil and a top 10 seller in vapes across B.C.
  • CEO Paul Pedersen sat down with Coreena Robertson to add context to the results and discuss what to expect from the company in the future
  • Nextleaf Solutions is a manufacturer and distributor of cannabis vapes and oils across Canada and internationally
  • Nextleaf (OILS) is down by 10 per cent trading at $0.045 per share

Nextleaf (OILS) has announced audited financial results for fiscal 2022, which ended September 30, 2022.

Select financial highlights

  • Revenue was $5,351,509, up by 52 per cent YoY
  • Cost of sales was $3,748,621, down by 12 per cent YoY
  • Gross profit came in at $661,238

Select operational highlights

  • The company ended 2022 as a top 5 seller of CBD oil and a top 10 seller in vapes across B.C.
  • It validated its technology to produce THC-free broad spectrum CBD distillate from industrial hemp feedstock. It launched its first THC-free CBD product subsequent to fiscal year end
  • It also became the first company in Canada to produce THC-O, which is not subject to excise tax

Subsequent to fiscal year end, Nextleaf entered the Newfoundland and Labrador market and completed its first international shipment of cannabis vape products.

CEO Paul Pedersen sat down with Coreena Robertson to add context to the results and discuss what to expect from the company in the future.

Nextleaf Solutions is a manufacturer and distributor of cannabis vapes and oils across Canada and internationally. Its flagship brand is the award-winning Glacial Gold.

Nextleaf (OILS) is down by 10 per cent trading at $0.045 per share as of 1:04 pm EST.


More From The Market Online

StockTalk | Cannabis Report: Hostile takeover?

Curaleaf (TSX: CURA / OTCQX: CURLF) announced a takeover bid for Aurora Cannabis (TSX: ACB / NASDAQ: ACB),...
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Potent Q2 results

Curaleaf to acquire Aurora Cannabis. (Source: Google Gemini. Generated by AI) Curaleaf (TSX:CURA) intends to make...

Cannabis microcap posts potent Q2 results

MediPharm Labs (TSX:LABS), a cannabis-focused pharma company, elevated into positive net income in Q2 2026.